openPR Logo
Press release

Insulin Pens Market Growing at 8.8% CAGR to Reach $8,286.6 Million by 2027 Fuelled by Pendiq, Emperra GmbH E-Health Technologies, Novo Nordisk, Owen Mumford, Sanofi, Ypsomed, Biocon, Companion Medical, BERLIN CHEMIE, Eli Lilly and Company

05-16-2019 02:52 PM CET | Health & Medicine

Press release from: The Insight Partners

/ PR Agency: The Insight Partners
Insulin Pens Market Growth Potentially Worth USD 8,286.6 Million by 2027

Insulin Pens Market Growth Potentially Worth USD 8,286.6 Million by 2027

The global insulin pens market to grow with a CAGR of 8.8% to reach $8,286.6 Million in 2027 from $3,957.0 Million in 2018 Fuelled by Rising Incidence of Diabetes
And Growing Market in Developing Economies.

The Asia Pacific insulin pens market is expected to grow at the highest rate during the forecast period. The growth is contributed majorly by driving factors such as a significant rise in the prevalence of diabetes across the countries, rise in the government support for diabetes care. In addition, the market players are also supporting diabetes care in the countries through creating awareness and various initiatives.

Get Sample PDF Brochure of this Premium Research Report at https://www.theinsightpartners.com/sample/TIPRE00004650/?Op-pK

Insulin Pens Market Key Company Profiles:
• Novo Nordisk A/S
• Owen Mumford
• Sanofi
• Ypsomed AG
• Biocon
• Companion Medical
• BERLIN CHEMIE AG
• Eli Lilly and Company
• Pendiq GmbH
• Emperra GmbH E-Health Technologies

Market Insights:

Diabetes is a life-threatening chronic disease with no specialized cure. It is mainly caused by the body’s inability to produce or effectively utilize the hormone insulin. This inability prevents the body from adequately regulating blood glucose levels. There are two types of diabetes, namely diabetes type-I and diabetes type-II also termed as diabetes mellitus. Incidences and the prevalence of diabetes are steadily increasing across the globe. Type 2 diabetes is the most common form of diabetes and has grown alongside cultural and societal changes. In high-income countries, up to 91% of adults with the disease have type 2 diabetes. According to the International Diabetes Federation (IDF), approximately 425 million people were living with diabetes in 2017, and it is expected to reach 629 million by 2045 across the globe. Additionally, according to BMJ Open Diabetes Research & Care, approximately 387 million patients across the globe have diabetes, out of which 5-10% are victims of type-1 diabetes that require regular insulin doses. The rising incidence is thus likely expected to promote the growth of insulin pens market.

The emerging markets in the developing countries are the major factor which is giving a better opportunity for the major players to expand their business. These are becoming a primary reason for the market growth in the forecast period. The developed countries depend on a healthcare model in which healthcare professions treat medical conditions with the help of medications and surgeries.

However, in developing countries, more focus is on holistic and conventional treatment methods in large scale. Significant differences between developed and developing countries are resources like money, infrastructure, skilled workforce, education, and products. Healthcare in developing countries is undergoing rapid changes. The healthcare systems in those countries are facing challenges such as the burden of rising and aging populations, and with it, the delivery of adequate healthcare to the masses. Brazil, Russia, India, China, and South Africa (BRICS) are among the fastest growing economies of the world. Thus, with the increasing healthcare industry and increasing government initiatives, the demand for insulin pens is expected to increase in the developing economies.

Product Type Insights:

The insulin pens market on the basis of product type is segmented in to disposable and reusable. In 2018, the disposable segment held the largest market share of 62.6% of the insulin pens market, by product type. The disposable insulin pens are expected to dominate its market share in 2027 owing to the advantages offered by these type that include ease of use, low cost, less threat of needle-stick infection, and others. The similar segment is also anticipated to witness the fastest growth rate of 9.0% during the forecast period, 2019 to 2027 owing to its rising usage as pre-filled cartridges in the newly launched insulin dosages by leading pharmaceutical manufacturers.

Strategic Insights:

Product launches and expansions were observed as the most adopted strategy in global insulin pens industry. For instance, in April 2016, Emperra GmbH launched a new Bluetooth insulin pen model. The new ESYSTA BT pen is equipped with a Bluetooth interface and transfers the injected insulin doses directly to the patient’s digital blood glucose diary. Thus, the innovative product launch move by the company is likely to boost up the growth of its own and is likely to contribute to the market in the coming future.

Place a Direct Purchase Order to Acquire a Copy of this Report at https://www.theinsightpartners.com/buy/TIPRE00004650/?Op-pK


INSULIN PENS MARKET SEGMENTATION

Global Insulin Pens Market - By Product Type
• Reusable
• Disposable

Global Insulin Pens Market - By Application
• Diabetes Type-1
• Diabetes Type-2

Global Insulin Pens Market - By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• E-Commerce

By Geography
• North America
o U.S.
o Canada
o Mexico

• Europe
o France
o Germany
o UK
o Spain
o Italy

• Asia Pacific (APAC)
o China
o India
o Japan
o Australia
o South Korea

• Middle East & Africa (MEA)
o Saudi Arabia
o South Africa
o UAE

• South America (SAM)
o Brazil
o Argentina

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
Website: www.theinsightpartners.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Insulin Pens Market Growing at 8.8% CAGR to Reach $8,286.6 Million by 2027 Fuelled by Pendiq, Emperra GmbH E-Health Technologies, Novo Nordisk, Owen Mumford, Sanofi, Ypsomed, Biocon, Companion Medical, BERLIN CHEMIE, Eli Lilly and Company here

News-ID: 1742218 • Views: 516

More Releases from The Insight Partners

Explore Sports Medicine Devices Market Growing Popularity with Top Industry Play …
This study offers a comprehensive analysis on the Sports Medicine Devices Market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Sports Medicine Devices Market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies. The market for sports
Embolization Coils Market 2020 Analysis | Terumo, Medtronic, Stryker, Cook, DePu …
This intelligent report encloses comprehensive analysis on the Embolization Coils market and are assessed through volume and value data validated on three approaches including top companies revenues. It concludes with precise and authentic market estimations considering all the parameters and market dynamics. Every crucial and decisive detail for the development and restriction of the market is mentioned in fine points with solutions and suggestions that may affect the market
Healthcare BPO Services Market Business Overview, Status and Prospect, Forecast …
The global healthcare BPO services is expected to reach US$ 416,431.8 Mn in 2025 from US$ 192,131.6 Mn in 2017. The market is estimated to grow with a CAGR of 10.4% from 2018-2025. Healthcare BPO services is segmented by payer service, provider service, and pharmaceutical service. Global healthcare BPO services, based on payer service was segmented into claims administration, billing, member management, provider management, fraud management, and others. Global healthcare BPO
Hot Sauce Market: Year 2020-2027 and its detail analysis by focusing on top key …
The research report provides a big picture on "Hot Sauce market" 2027, on a global basis, offering a forecast and statistic in terms of revenue during the forecast period. This report covers detailed segmentation, complete R & D history, and explanatory analysis including the latest news. Furthermore, the study explains the future opportunities and a sketch of key players involved in the "Hot Sauce hike in terms of revenue. Get sample

All 5 Releases


More Releases for Insulin

Insulin Patch Pumps Market Report 2018: Segmentation by Insulin Type (Bolus Insu …
Global Insulin Patch Pumps market research report provides company profile for Roche Holding AG, Cellnovo Group SA, Spring Health Solution Ltd., Debiotech, CeQur SA, Valeritas, Becton Dickenson & Company, Insulet Corporation, Johnson & Johnson, Medtrum Technologies Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue,
Insulin Delivery Devices Market - Insights
Insulin is vital for people suffering from type 1 diabetes and type 2 diabetes. In the past, patients with diabetes had to inject insulin using large glass syringes and reusable needles, both of which needed sterilization by boiling after each use. Improvements and innovations has led to development of insulin delivery devices such as pens and insulin pumps. Furthermore, insulin analogs have become available that enable both continuous subcutaneous insulin
Biosimilar Insulin Market Access
Boston, MA ReportsWorldwide has announced the addition of a new report title Biosimilar Insulin Market Access to its growing collection of premium market research reports. Biosimilar competition is providing payers with opportunities to contain costs in a category that accounts for a significant proportion of total drug expenditure. The launch of the biosimilar insulin Basaglar is a threat to the insulin-based product market, which includes long-time reference product Lantus as well as newer
Biosimilar Insulin Market Access
ReportsWorldwide has announced the addition of a new report title Biosimilar Insulin Market Access to its growing collection of premium market research reports. Biosimilar competition is providing payers with opportunities to contain costs in a category that accounts for a significant proportion of total drug expenditure. The launch of the biosimilar insulin Basaglar is a threat to the insulin-based product market, which includes long-time reference product Lantus as well as newer entrants
Biosimilar Insulin Market Biosimilar Insulin Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Prologue to Insulin Biosimilars 1.1 Outline Towards Insulin 1.2 Trail of Insulin Evolution and Development Rationale Design of Insulin Molecule 2.1 Structure of Insulin Polypeptide 2.2 Biosynthesis of Insulin 2.3 Secretion of Insulin Mechanism of Insulin in Diabetics 3.1 Glucose Metabolism of Insulin 3.2 Impact of Insulin Dysregulation in Diabetes 1 3.3 Impact
Global Insulin Delivery Machine Market: By Types - Insulin Pens, Insulin Pumps, …
Latest industry research report on: Global Insulin Delivery Machine Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Request For Sample Report @https://www.marketresearchreports.biz/sample/sample/1181480 This report studies Insulin Delivery Machine in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in